Graft-Versus-Host Disease (GVHD) Clinical Trials and Research

Graft-Versus-Host Disease (GVHD) Clinical Trials and Research

Share
Print
Share
Print

MSK has many doctors and scientists who are studying the best ways to prevent and treat graft-versus-host disease (GVHD).

Much of this research is focused on methods to prevent GVHD by removing immune cells called T cells from the donor graft — a process known as T cell depletion.

We are also evaluating a number of other approaches, including the use of clinical risk-score for treatment customization and 3D digital photography and reflectance confocal microscopy to evaluate tissues in a noninvasive way.

We are also doing research in the clinic and in the lab in a number of areas including gut tissue regeneration, the microbiota (the community of organisms that live in the body, especially in the gut), and photobiomodulation (a form of light therapy).

Our experts can help determine which clinical trials may be right for you. The following clinical trials for GVHD are currently enrolling new patients. To learn more about a particular study, choose from the list below.

Learn more about clinical trials